David J. McCann

1.1k total citations
26 papers, 698 citations indexed

About

David J. McCann is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, David J. McCann has authored 26 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cellular and Molecular Neuroscience, 9 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in David J. McCann's work include Neuroscience and Neuropharmacology Research (8 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Pharmacological Receptor Mechanisms and Effects (6 papers). David J. McCann is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Pharmacological Receptor Mechanisms and Effects (6 papers). David J. McCann collaborates with scholars based in United States, Israel and Canada. David J. McCann's co-authors include Tsung‐Ping Su, J.C. Winter, Arthur D. Weissman, Richard A. Rabin, Phil Skolnick, Earle Bain, Thomas Laughren, Thomas Shiovitz, Adam Hanina and Stephanie Rens‐Domiano and has published in prestigious journals such as New England Journal of Medicine, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.

In The Last Decade

David J. McCann

26 papers receiving 681 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David J. McCann United States 16 352 349 89 69 67 26 698
Anne Roussin France 16 219 0.6× 167 0.5× 99 1.1× 146 2.1× 58 0.9× 42 696
Judy M. Harrer United States 15 175 0.5× 347 1.0× 127 1.4× 177 2.6× 98 1.5× 16 865
R. K. S. Lim United States 13 222 0.6× 102 0.3× 129 1.4× 49 0.7× 68 1.0× 19 890
Markéta Marvanová United States 12 175 0.5× 134 0.4× 48 0.5× 33 0.5× 101 1.5× 32 611
Bradford D. Fischer United States 15 323 0.9× 215 0.6× 67 0.8× 92 1.3× 41 0.6× 36 645
Anders Hammarberg Sweden 18 271 0.8× 106 0.3× 121 1.4× 114 1.7× 93 1.4× 52 994
Jochen Mutschler Germany 16 155 0.4× 92 0.3× 96 1.1× 127 1.8× 97 1.4× 57 723
Stefano Milleri Italy 17 64 0.2× 188 0.5× 111 1.2× 49 0.7× 45 0.7× 37 747
Gail Somer Canada 12 235 0.7× 107 0.3× 123 1.4× 135 2.0× 82 1.2× 19 658
Noah R. Gubner United States 15 130 0.4× 122 0.3× 46 0.5× 79 1.1× 22 0.3× 41 555

Countries citing papers authored by David J. McCann

Since Specialization
Citations

This map shows the geographic impact of David J. McCann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. McCann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. McCann more than expected).

Fields of papers citing papers by David J. McCann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. McCann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. McCann. The network helps show where David J. McCann may publish in the future.

Co-authorship network of co-authors of David J. McCann

This figure shows the co-authorship network connecting the top 25 collaborators of David J. McCann. A scholar is included among the top collaborators of David J. McCann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. McCann. David J. McCann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McCann, David J., et al.. (2023). Results of a randomized, double-blind, placebo-controlled trial of lorcaserin in cocaine use disorder. Drug and Alcohol Dependence. 255. 111063–111063. 3 indexed citations
2.
3.
Gilgun‐Sherki, Yossi, Rom E. Eliaz, David J. McCann, et al.. (2016). Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependence. Drug and Alcohol Dependence. 166. 13–20. 32 indexed citations
4.
McCann, David J., et al.. (2015). Medication Nonadherence, “Professional Subjects,” and Apparent Placebo Responders. Journal of Clinical Psychopharmacology. 35(5). 566–573. 41 indexed citations
5.
McCann, David J., Tatiana Ramey, & Phil Skolnick. (2015). Outcome Measures in Medication Trials for Substance Use Disorders. Current Treatment Options in Psychiatry. 2(2). 113–121. 20 indexed citations
6.
McCann, David J., et al.. (2011). A Novel, Nonbinary Evaluation of Success and Failure Reveals Bupropion Efficacy Versus Methamphetamine Dependence: Reanalysis of a Multisite Trial. CNS Neuroscience & Therapeutics. 18(5). 414–418. 31 indexed citations
7.
Schindler, Charles W., et al.. (2011). Comparison of the effects of methamphetamine, bupropion, and methylphenidate on the self-administration of methamphetamine by rhesus monkeys.. Experimental and Clinical Psychopharmacology. 19(1). 1–10. 26 indexed citations
8.
Montoya, Iván D. & David J. McCann. (2010). Drugs of abuse: management of intoxication and antidotes. Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions. 100. 519–541. 15 indexed citations
9.
McCann, David J., et al.. (2005). Sixth cranial nerve palsy. Journal of Emergency Medicine. 29(2). 207–211. 2 indexed citations
10.
McCann, David J.. (1999). SELEGILINE AS A POTENTIAL COCAINE TREATMENT MEDICATION. Behavioural Pharmacology. 10(SUPPLEMENT 1). S60–S60. 2 indexed citations
11.
McCann, David J., Arthur D. Weissman, & Tsung‐Ping Su. (1994). Sigma‐1 and Sigma‐2 sites in rat brain: Comparison of regional, ontogenetic, and subcellular patterns. Synapse. 17(3). 182–189. 97 indexed citations
12.
Weissman, Arthur D., David J. McCann, Joan F. Lorden, & Tsung‐Ping Su. (1993). An absence of changes in σ receptor subtypes in the brains of genetically dystonic (dt) rats. European Journal of Pharmacology. 250(2). 329–332. 3 indexed citations
13.
McCann, David J. & Tsung‐Ping Su. (1992). Tris inhibits (+)-[3H]SKF-10,047 binding to σ receptors. Neuroscience Letters. 141(2). 239–242. 2 indexed citations
14.
Zaczek, Robert, Steven Culp, Harry Goldberg, David J. McCann, & E B De Souza. (1991). Interactions of [3H]amphetamine with rat brain synaptosomes. I. Saturable sequestration.. Journal of Pharmacology and Experimental Therapeutics. 257(2). 820–829. 34 indexed citations
15.
McCann, David J. & Tsung‐Ping Su. (1991). Solubilization and characterization of haloperidol-sensitive (+)-[3H]SKF-10,047 binding sites (sigma sites) from rat liver membranes.. Journal of Pharmacology and Experimental Therapeutics. 257(2). 547–554. 61 indexed citations
16.
McCann, David J. & Tsung‐Ping Su. (1990). Haloperidol competitively inhibits the binding of (+)-[3H]SKF-10,047 to σ sites. European Journal of Pharmacology. 180(2-3). 361–364. 23 indexed citations
17.
McCann, David J. & Tsung‐Ping Su. (1990). Haloperidol-sensitive (+)[3H]SKF-10,047 binding sites (σ sites) exhibit a unique distribution in rat brain subcellular fractions. European Journal of Pharmacology Molecular Pharmacology. 188(4-5). 211–218. 62 indexed citations
18.
McCann, David J., Richard A. Rabin, Stephanie Rens‐Domiano, & J.C. Winter. (1989). Phencyclidine/SKF-10,047 binding sites: Evaluation of function. Pharmacology Biochemistry and Behavior. 32(1). 87–94. 45 indexed citations
19.
McCann, David J., Richard A. Rabin, & J.C. Winter. (1987). Use of the radial maze in studies of phencyclidine and other drugs of abuse. Physiology & Behavior. 40(6). 805–812. 20 indexed citations
20.
McCann, David J. & J.C. Winter. (1986). Effects of phencyclidine, N-allyl-N-normetazocine (SKF-10,047), and verapamil on performance in a radial maze. Pharmacology Biochemistry and Behavior. 24(2). 187–191. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Roussin Breakdown of academic impact, for papers by Judy M. Harrer Breakdown of academic impact, for papers by R. K. S. Lim Breakdown of academic impact, for papers by Markéta Marvanová Breakdown of academic impact, for papers by Bradford D. Fischer Breakdown of academic impact, for papers by Anders Hammarberg Breakdown of academic impact, for papers by Jochen Mutschler Breakdown of academic impact, for papers by Stefano Milleri Breakdown of academic impact, for papers by Gail Somer Breakdown of academic impact, for papers by Noah R. Gubner
Rankless by CCL
2026